title: Characteristics and management of erectile dysfunction after various treatments for prostate cancer.
authors.forename: Jintetsu
authors.initials: J
authors.lastname: Soh
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kaiho
authors.forename: Eiji
authors.initials: E
authors.lastname: Kikuchi
authors.forename: Mototsugu
authors.initials: M
authors.lastname: Oya
authors.forename: Kunihiko
authors.initials: K
authors.lastname: Yoshioka
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Nakagami
authors.forename: Tadashi
authors.initials: T
authors.lastname: Hatano
authors.forename: Choichirou
authors.initials: C
authors.lastname: Ozu
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Horiguchi
authors.forename: Kazunori
authors.initials: K
authors.lastname: Namiki
authors.forename: Masaaki
authors.initials: M
authors.lastname: Tachibana
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Hisasue
authors.forename: Nobumichi
authors.initials: N
authors.lastname: Tanaka
authors.forename: Isao
authors.initials: I
authors.lastname: Asakawa
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001918:Brachytherapy / Q000009:adverse effects*; D007172:Erectile Dysfunction / Q000209:etiology* / Q000534:rehabilitation*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011468:Prostatectomy / Q000009:adverse effects* / Q000379:methods; D011471:Prostatic Neoplasms / Q000628:therapy*; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects*; D012371:Robotics
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D010726:Phosphodiesterase Inhibitors